Pharmacovigilance in China: issues of concern identified through an analysis of the Chinese Adverse Drug Reaction Information Bulletin 2001 to 2014-Reference-Cited by-同舟云学术

Pharmacovigilance in China: issues of concern identified through an analysis of the Chinese Adverse Drug Reaction Information Bulletin 2001 to 2014

Published:2015-08-20 Issue:5 Volume:40 Page:594-598
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Gao P.¹,Zhang C. L.²,Zeng F. D.³,Pu R.⁴,Zhang J.⁵,Huang R.⁶,Liu D.²

Affiliation:

1. Department of Pharmacy; Wuhan Children's Hospital; Wuhan Hubei China

2. Department of Pharmacy; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan Hubei China

3. Department of Pharmacology; Tongji Medical College; Huazhong University of Science and Technology; Wuhan Hubei China

4. China National Center for Biotechnology Development; Beijing China

5. Institute of Materia Medica; Chinese Academy of Medical Sciences; Beijing China

6. School of Pharmacy; Tongji Medical College; Huazhong University of Science and Technology; Wuhan Hubei China

Funder

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12317/fullpdf

Reference15 articles.

1. An overview of adverse drug reaction monitoring in China;Zhou;Int J Pharmaceut Med,2006

2. Drug safety surveillance in China and other countries: a review and comparison;Du;Value Health,2008

3. Adverse drug reaction information bulletin and risk management on drugs;Chen;Chin J Pharmacovigil,2007

4. EMA Guideline on Good Pharmacovigilance Practices (GVP) Module VI - Management and Reporting of Adverse Reactions to Medicinal Products http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/09/WC500172402.pdf

5. WHO The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products 2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. eHealth technologies assisting in identifying potential adverse interactions with complementary and alternative medicine (CAM) or standalone CAM adverse events or side effects: a scoping review;BMC Complementary Medicine and Therapies;2020-07-29

2. A Retrospective Analysis on 1330 Adverse Event Reports of Qingkailing in China: Further Perception of Its Risks and Rational Use;Current Medical Science;2018-12

3. Utilization and Safety of Hepatoprotective Drugs: A Retrospective Pharmacoepidemiology Study on Two Databases of China;Indian Journal of Pharmaceutical Sciences;2017